Financing - Health Technology Insights

P3 Health Partners Issues 2025 Guidance, Proposes Financing

February 14, 2025

Company provides preliminary 2025 guidance and advance notification of a proposed financing transaction to provide a $30 million unsecured promissory note. P3 Health Partners Inc.,

Northwest Biotherapeutics Announces $5 Million Convertible Note Financing

Northwest Biotherapeutics Secures $5M Convertible Note and $50M Facility

January 3, 2025

Northwest Biotherapeutics, a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced that it entered into a $5 million convertible Promissory Note

Categories

Tag: Financing

P3 Health Partners Issues 2025 Guidance, Proposes Financing

Northwest Biotherapeutics Secures $5M Convertible Note and $50M Facility

Share With

Recent Posts

Health Technology Insights: Latest News And Innovations – Roundup

QuidelOrtho Expands Leadership with Two Senior VP Appointments

Elekta, Gray Partner to Enhance Oncology Scheduling for ONE OIS

CRESSO Names Kelly Crompvoets CMO and Interim ARCpoint Labs President

Zenyth Partners Closes Fund II with $375 Million of Commitments

Quick Links

Insights

Get in touch

Follow Us

Our Other Brands